Lloyd Paul Aiello Named Director of Joslin's Beetham Eye Institute
Joslin Diabetes CenterLloyd Paul Aiello, M.D., Ph.D., a leader in the field of academic ophthalmology, recently was named Director of Joslin Diabetes Center's Beetham Eye Institute.
Lloyd Paul Aiello, M.D., Ph.D., a leader in the field of academic ophthalmology, recently was named Director of Joslin Diabetes Center's Beetham Eye Institute.
A multicenter international study brings hopeful news to the 18 million people in the United States "” and millions more worldwide "” with type 1 or type 2 diabetes.
Study showing role of PKC-beta 2 in diabetic complications to be presented at the American Diabetes Association 65th Scientific Sessions in San Diego.
Obesity, physical inactivity, genetics and age have long been recognized as risk factors for developing high blood glucose and diabetes. But over the past few years, scientists have discovered another risk -- low birth weight.
Joslin's new textbook is leading source for advances in diabetes care. 14th edition tailored to primary care and specialty practitioners.
Joslin's latest news release highlights a new study by C. Ronald Kahn, M.D., and a team of investigators that one day may lead to new ways to treat obesity in humans. Yu-Hua Tseng, Ph.D., along with Atul J. Butte, M.D., Ph.D., served as first author of the study.